Matches in SemOpenAlex for { <https://semopenalex.org/work/W2572954468> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2572954468 endingPage "1164" @default.
- W2572954468 startingPage "1164" @default.
- W2572954468 abstract "1164 Objectives The inducible GPCR B1 receptor (B1R) is a molecular signature of several types of solid cancers, including brain cancer. It is thought to be involved in tumor growth, invasion and angiogenesis. Thus, the B1R may represent a highly promising new target for the development of cancer-targeted theranostic agents. Methods We developed a new 64Cu/NOTA-conjugated analog of our potent, selective B1R peptide antagonist, R-954 (AcOrn[Oic2,(αMe)Phe5,DβNal7,Ile8]-desArg9-bradykinin). Stability of the resulting peptide conjugate was evaluated ex vivo in undiluted rat blood samples and in vivo within systemic circulation in healthy rats. Intracellular uptake/nuclear localization and radiocytotoxicity of the conjugate were studied in cultured F98 glioma cells. In vivo biodistribution profile and efficacy of detection of malignant brain tumors by PET, were evaluated using the syngeneic, orthotopic F98 glioma rat model. Results 64Cu/NOTA-βAla-R-954 showed remarkable stability in rat plasma after a 24h incubation. In vivo stability study showed mainly intact radiolabeled peptide (no occurrence of radiotracer metabolites) in rat blood circulation and urine, 90min after tail-vein injection. In vitro, the conjugate supressed, in a concentration-dependent manner, clonogenic growth of F98 cells possibly through an intracellular radiation mechanism (i.e. via cellular/nuclear uptake). Intravenous 64Cu/NOTA-βAla-R-954 properly detected relatively small brain tumors by PET at 1.5h and 20h after injection. Moreover, µPET signals coincided perfectly with those of contrast-enhanced MRI. The conjugate exhibited high tumor-to-contralateral background uptake and tumor-to-muscle uptake ratios (18:1 and 6:1, respectively) at 20h after injection. µPET signals generated by the radiotracer were i) inhibitable with excess of the unlabeled B1R antagonist R-954, ii) substantially reduced in B1R-knockdown F98 tumors, and iii) primarily absent in sham-operated animals, thus confirming the B1R-targeted tumor uptake specificity of the conjugate. Conclusions Our findings provide initial proof-of-concept for the potential use of 64Cu/NOTA-βAla-R-954 radiotracer in both diagnosis and treatment of brain cancer, and possibly other types of B1R-positive solid cancers." @default.
- W2572954468 created "2017-01-26" @default.
- W2572954468 creator A5014453985 @default.
- W2572954468 creator A5034571274 @default.
- W2572954468 creator A5053182265 @default.
- W2572954468 creator A5062439140 @default.
- W2572954468 creator A5065437733 @default.
- W2572954468 creator A5091832940 @default.
- W2572954468 date "2016-05-01" @default.
- W2572954468 modified "2023-09-23" @default.
- W2572954468 title "Theranostic potential of a new [64Cu]-radiolabeled R-954 conjugate for kinin B1R positive tumors" @default.
- W2572954468 hasPublicationYear "2016" @default.
- W2572954468 type Work @default.
- W2572954468 sameAs 2572954468 @default.
- W2572954468 citedByCount "0" @default.
- W2572954468 crossrefType "journal-article" @default.
- W2572954468 hasAuthorship W2572954468A5014453985 @default.
- W2572954468 hasAuthorship W2572954468A5034571274 @default.
- W2572954468 hasAuthorship W2572954468A5053182265 @default.
- W2572954468 hasAuthorship W2572954468A5062439140 @default.
- W2572954468 hasAuthorship W2572954468A5065437733 @default.
- W2572954468 hasAuthorship W2572954468A5091832940 @default.
- W2572954468 hasConcept C117262875 @default.
- W2572954468 hasConcept C134018914 @default.
- W2572954468 hasConcept C134306372 @default.
- W2572954468 hasConcept C150903083 @default.
- W2572954468 hasConcept C170493617 @default.
- W2572954468 hasConcept C185592680 @default.
- W2572954468 hasConcept C197336794 @default.
- W2572954468 hasConcept C202751555 @default.
- W2572954468 hasConcept C207001950 @default.
- W2572954468 hasConcept C26291073 @default.
- W2572954468 hasConcept C2777807558 @default.
- W2572954468 hasConcept C2778227246 @default.
- W2572954468 hasConcept C2779591629 @default.
- W2572954468 hasConcept C2780394083 @default.
- W2572954468 hasConcept C33923547 @default.
- W2572954468 hasConcept C502942594 @default.
- W2572954468 hasConcept C55493867 @default.
- W2572954468 hasConcept C71924100 @default.
- W2572954468 hasConcept C86803240 @default.
- W2572954468 hasConcept C98274493 @default.
- W2572954468 hasConceptScore W2572954468C117262875 @default.
- W2572954468 hasConceptScore W2572954468C134018914 @default.
- W2572954468 hasConceptScore W2572954468C134306372 @default.
- W2572954468 hasConceptScore W2572954468C150903083 @default.
- W2572954468 hasConceptScore W2572954468C170493617 @default.
- W2572954468 hasConceptScore W2572954468C185592680 @default.
- W2572954468 hasConceptScore W2572954468C197336794 @default.
- W2572954468 hasConceptScore W2572954468C202751555 @default.
- W2572954468 hasConceptScore W2572954468C207001950 @default.
- W2572954468 hasConceptScore W2572954468C26291073 @default.
- W2572954468 hasConceptScore W2572954468C2777807558 @default.
- W2572954468 hasConceptScore W2572954468C2778227246 @default.
- W2572954468 hasConceptScore W2572954468C2779591629 @default.
- W2572954468 hasConceptScore W2572954468C2780394083 @default.
- W2572954468 hasConceptScore W2572954468C33923547 @default.
- W2572954468 hasConceptScore W2572954468C502942594 @default.
- W2572954468 hasConceptScore W2572954468C55493867 @default.
- W2572954468 hasConceptScore W2572954468C71924100 @default.
- W2572954468 hasConceptScore W2572954468C86803240 @default.
- W2572954468 hasConceptScore W2572954468C98274493 @default.
- W2572954468 hasLocation W25729544681 @default.
- W2572954468 hasOpenAccess W2572954468 @default.
- W2572954468 hasPrimaryLocation W25729544681 @default.
- W2572954468 hasRelatedWork W1047575269 @default.
- W2572954468 hasRelatedWork W117083775 @default.
- W2572954468 hasRelatedWork W128136065 @default.
- W2572954468 hasRelatedWork W2100967833 @default.
- W2572954468 hasRelatedWork W2108500243 @default.
- W2572954468 hasRelatedWork W2110184913 @default.
- W2572954468 hasRelatedWork W2158699407 @default.
- W2572954468 hasRelatedWork W2223061329 @default.
- W2572954468 hasRelatedWork W2481653278 @default.
- W2572954468 hasRelatedWork W2487122036 @default.
- W2572954468 hasRelatedWork W2529327287 @default.
- W2572954468 hasRelatedWork W2566119508 @default.
- W2572954468 hasRelatedWork W2576982875 @default.
- W2572954468 hasRelatedWork W2755180874 @default.
- W2572954468 hasRelatedWork W2805484681 @default.
- W2572954468 hasRelatedWork W3024495124 @default.
- W2572954468 hasRelatedWork W3095845621 @default.
- W2572954468 hasRelatedWork W3127217725 @default.
- W2572954468 hasRelatedWork W3214720790 @default.
- W2572954468 hasRelatedWork W2158034762 @default.
- W2572954468 hasVolume "57" @default.
- W2572954468 isParatext "false" @default.
- W2572954468 isRetracted "false" @default.
- W2572954468 magId "2572954468" @default.
- W2572954468 workType "article" @default.